These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1480527)

  • 1. [Pharmacokinetics of urinary excretion of methotrexate (MTX) in patients with malignant tumors].
    Skibińska L
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):545-8. PubMed ID: 1480527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of central nervous system tumors with methotrexate.
    Abelson HT; Kufe DW; Skarin AT; Major P; Ensminger W; Beardsley GP; Canellos GP
    Cancer Treat Rep; 1981; 65 Suppl 1():137-40. PubMed ID: 6976830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
    Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.
    Gerber DE; Grossman SA; Batchelor T; Ye X
    Cancer Chemother Pharmacol; 2007 May; 59(6):817-23. PubMed ID: 16972068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of high and moderate intravenous doses of methotrexate.
    Awidi A; al-Turk A; Madanat F; Othman S; Shaheen O
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):411-4. PubMed ID: 3363225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of high doses of methotrexate in face and neck epithelial tumors].
    Perlado F; Mateo Ruíz P; Zubiri Vidal A
    Actas Dermosifiliogr; 1979; 70(3-4):279-84. PubMed ID: 484296
    [No Abstract]   [Full Text] [Related]  

  • 9. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
    Inuyama Y; Taketa C; Hiroto I; Fujii M; Takaoka T; Tanaka J; Matsuura S; Satake B; Takeoda S; Nishijima W
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1823-31. PubMed ID: 6332576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
    Fukuhara K; Ikawa K; Morikawa N; Kumagai K
    J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Sinnett MJ; Groff GD; Raddatz DA; Franck WA; Bertino JS
    J Rheumatol; 1989 Jun; 16(6):745-8. PubMed ID: 2674426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
    Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic study of mitoxantrone].
    Ogawa M; Sampi K; Tsukui T; Oguro M; Sakai K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3028-33. PubMed ID: 3767389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
    Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
    Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
    Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
    J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose oral methotrexate.
    McVie JG; Stuart JF; Calman KC; Reid JL
    Cancer Treat Rep; 1981; 65 Suppl 1():141-3. PubMed ID: 7198935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and dichloromethotrexate: a pharmacologically rational combination.
    Natale RB; Wheeler RH; Roberts JA
    NCI Monogr; 1987; (5):219-23. PubMed ID: 3431592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
    Sampi K; Hattori M
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of small doses of methotrexate in patients with psoriasis.
    Kamel RS; al-Hakiem MH; Rademaker M; Meyrick Thomas RH; Munro DD
    Acta Derm Venereol; 1988; 68(3):267-70. PubMed ID: 2455425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.